Cambrex Corporation (CBM) financial statements (2021 and earlier)

Company profile

Business Address ONE MEADOWLANDS PLZ
E RUTHERFORD, NJ 07073
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments961837444462324
Cash and cash equivalents961837444462324
Receivables1529611798777143
Inventory, net of allowances, customer advances and progress billings111139123110869071
Inventory111139123110869071
Prepaid expense and other current assets6
Deferred tax assets    43 
Other undisclosed current assets524871516 
Total current assets:410422323259228203144
Noncurrent Assets
Property, plant and equipment361254217186164172152
Long-term investments and receivables    11315
Long-term investments    11315
Intangible assets, net (including goodwill)448575539534341
Goodwill261444032443937
Intangible assets, net (excluding goodwill)18714157944
Other noncurrent assets334248
Prepaid expense and other noncurrent assets3
Deferred tax assets, net    3820 
Other undisclosed noncurrent assets131319  39
Total noncurrent assets:813318289246260255250
TOTAL ASSETS:1,223741612506487458394
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities93788884117114104
Accounts payable47354339442928
Accrued liabilities44433644414844
Employee-related liabilities    272623
Taxes payable209 51010
Debt   30   
Deferred revenue and credits5816142012
Deferred tax liabilities    (0)(0)1
Contract with customer, liability12
Other undisclosed current liabilities    (32)(36)(33)
Total current liabilities:1048395130999783
Noncurrent Liabilities
Long-term debt and lease obligation    607964
Long-term debt, excluding current maturities    607964
Liabilities, other than long-term debt16511311165777184
Deferred revenue and credits3939    
Pension and other postretirement defined benefit plans, liabilities4055
Contract with customer, liability43
Deferred tax liabilities, net57878111319
Liability, pension and other postretirement and postemployment benefits4241434351
Other liabilities23252215161810
Other undisclosed noncurrent liabilities300      
Total noncurrent liabilities:46511311165137151148
Total liabilities:570196206195236248231
Stockholders' equity
Stockholders' equity attributable to parent654545405311251210163
Common stock3333333
Treasury stock, value(11)(12)(14)(15)(15)(15)(15)
Additional paid in capital183166154132119110104
Accumulated other comprehensive loss(60)(42)(66)(55)(45)(19)(34)
Retained earnings538430327246188131105
Total stockholders' equity:654545405311251210163
TOTAL LIABILITIES AND EQUITY:1,223741612506487458394

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues532534491433376322277
Revenue, net534491433375318277
Cost of revenue
(Cost of Goods and Services Sold)
(335)(304)(286)(256)(256)(218)(189)
Other undisclosed gross profit    4(2)3
Gross profit:19723020417712410390
Operating expenses(95)(87)(76)(86)(66)(58)(56)
Other undisclosed operating income (loss)    (6)52
Operating income:10114312891525036
Nonoperating income (expense)(1)0(0)00(0)(0)
Foreign currency transaction gain (loss), before tax1(1)0(1)0  
Interest and debt expense     (2)(2)
Income from continuing operations before equity method investments, income taxes:10114312891524733
Loss from equity method investments    (5)(2)(2)
Other undisclosed income (loss) from continuing operations before income taxes9(1)(1)(2)(2)  
Income from continuing operations before income taxes:11014212890464531
Income tax expense (benefit)(17)(38)(40)(32)13(15)32
Income from continuing operations:931048757583063
Income (loss) from discontinued operations(1)(1)(6)0(1)20
Net income:921028257573364
Other undisclosed net loss attributable to parent     (7)(1)
Net income available to common stockholders, diluted:921028257572662

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income:921028257573364
Other comprehensive income (loss)(18)23(10)(10)(26)15(3)
Comprehensive income:751267247314861
Other undisclosed comprehensive loss, net of tax, attributable to parent     (7)(1)
Comprehensive income, net of tax, attributable to parent:751267247314160

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: